31 may Global-Epinephrine-Autoinjector-Market-by-Manufact

Global Epinephrine Autoinjector Market by
Manufacturers, Regions, Type and Application,
Forecast to 2021
No of Pages – 123
Publishing Date - August 1, 2016
Browse detailed TOC, Tables, Figures, Charts in Global Epinephrine Autoinjector Market by
Manufacturers, Regions, Type and Application, Forecast to 2021 at -
http://www.360marketupdates.com/10222957
Epinephrine is the only treatment for a severe allergic reaction known as anaphylaxis (anna-fih-
LACK-sis). Epinephrine comes in the form of easy-to-use auto-injectors. It is only available through
a prescription by doctors. Each prescription comes with two auto-injectors in a set.
Epinephrine auto-injector is an emergency injection ("shot") of epinephrine. It is used against life-
threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure.
Scope of the Report:
This report focuses on the Epinephrine Autoinjector in Global market, especially in North America,
Europe and Asia-Pacific, Latin America, Middle and Africa. This report categorizes the market based
on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Mylan, Sanofi, ALK Abello, Impax.
Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
Latin America, Middle and Africa
Market Segment by Type, covers
0.30 mg Epinephrine Autoinjector
0.15 mg Epinephrine Autoinjector
Market Segment by Applications, can be divided into
Under 6 Years Patients
6 to 12 Years
Over 12 Years
There are 11 Chapters to deeply display the global Epinephrine Autoinjector market.
Chanter 1, to analyze the top manufacturers of Epinephrine Autoinjector, with sales, revenue, and
price of Epinephrine Autoinjector, in 2015 and 2016;